Industry: Chemical & Material
Published Date: 2025-06-08
Pages: 127 Pages
Report ld: 4760651
Request Sample
Customized Report
Orthopedics Biomaterials Market Size(US$)

CAGR 2025-2031
6.8%
Market Size,2031
USD 1,045
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Orthopedics Biomaterials was estimated to be worth US$ 673 million in 2024 and is forecast to a readjusted size of US$ 1045 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Orthopedics Biomaterials cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Orthopedics Biomaterials are biomedical materials used to repair, replace or enhance the function of human bone tissue, aiming to promote bone healing, regeneration and functional recovery. These materials are implanted into the human body to form a biocompatible bond with bone tissue and restore the anatomical structure and physiological function of bones. The core requirements include good biocompatibility, mechanical properties, wear resistance and the ability to bond with bone tissue.
North American market for Orthopedics Biomaterials was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Orthopedics Biomaterials was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Orthopedics Biomaterials was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Orthopedics Biomaterials include Arctic Biomaterials, Zimmer Biomet, Evonik, Geistlich Pharma AG, Invibio, Medbone, Medtronic, Olympus Corporation, OSARTIS GmbH, SigmaGraft Biomaterials, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Orthopedics Biomaterials, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Orthopedics Biomaterials by region & country, by Type, and by Application.
The Orthopedics Biomaterials market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orthopedics Biomaterials.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Orthopedics Biomaterials manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Orthopedics Biomaterials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Orthopedics Biomaterials in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Orthopedics Biomaterials Product Introduction
1.2 Global Orthopedics Biomaterials Market Size Forecast
1.2.1 Global Orthopedics Biomaterials Sales Value (2020-2031)
1.2.2 Global Orthopedics Biomaterials Sales Volume (2020-2031)
1.2.3 Global Orthopedics Biomaterials Sales Price (2020-2031)
1.3 Orthopedics Biomaterials Market Trends & Drivers
1.3.1 Orthopedics Biomaterials Industry Trends
1.3.2 Orthopedics Biomaterials Market Drivers & Opportunity
1.3.3 Orthopedics Biomaterials Market Challenges
1.3.4 Orthopedics Biomaterials Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Orthopedics Biomaterials Players Revenue Ranking (2024)
2.2 Global Orthopedics Biomaterials Revenue by Company (2020-2025)
2.3 Global Orthopedics Biomaterials Players Sales Volume Ranking (2024)
2.4 Global Orthopedics Biomaterials Sales Volume by Company Players (2020-2025)
2.5 Global Orthopedics Biomaterials Average Price by Company (2020-2025)
2.6 Key Manufacturers Orthopedics Biomaterials Manufacturing Base and Headquarters
2.7 Key Manufacturers Orthopedics Biomaterials Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Orthopedics Biomaterials
2.9 Orthopedics Biomaterials Market Competitive Analysis
2.9.1 Orthopedics Biomaterials Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Orthopedics Biomaterials Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orthopedics Biomaterials as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bioceramics
3.1.2 Bioactive Glass
3.1.3 Polymer
3.1.4 Others
3.2 Global Orthopedics Biomaterials Sales Value by Type
3.2.1 Global Orthopedics Biomaterials Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Orthopedics Biomaterials Sales Value, by Type (2020-2031)
3.2.3 Global Orthopedics Biomaterials Sales Value, by Type (%) (2020-2031)
3.3 Global Orthopedics Biomaterials Sales Volume by Type
3.3.1 Global Orthopedics Biomaterials Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Orthopedics Biomaterials Sales Volume, by Type (2020-2031)
3.3.3 Global Orthopedics Biomaterials Sales Volume, by Type (%) (2020-2031)
3.4 Global Orthopedics Biomaterials Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Fracture repair
4.1.2 Bone defect filling
4.1.3 Joint reconstruction
4.1.4 Bone tissue engineering
4.1.5 Sports medicine
4.1.6 Others
4.2 Global Orthopedics Biomaterials Sales Value by Application
4.2.1 Global Orthopedics Biomaterials Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Orthopedics Biomaterials Sales Value, by Application (2020-2031)
4.2.3 Global Orthopedics Biomaterials Sales Value, by Application (%) (2020-2031)
4.3 Global Orthopedics Biomaterials Sales Volume by Application
4.3.1 Global Orthopedics Biomaterials Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Orthopedics Biomaterials Sales Volume, by Application (2020-2031)
4.3.3 Global Orthopedics Biomaterials Sales Volume, by Application (%) (2020-2031)
4.4 Global Orthopedics Biomaterials Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Orthopedics Biomaterials Sales Value by Region
5.1.1 Global Orthopedics Biomaterials Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Orthopedics Biomaterials Sales Value by Region (2020-2025)
5.1.3 Global Orthopedics Biomaterials Sales Value by Region (2026-2031)
5.1.4 Global Orthopedics Biomaterials Sales Value by Region (%), (2020-2031)
5.2 Global Orthopedics Biomaterials Sales Volume by Region
5.2.1 Global Orthopedics Biomaterials Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Orthopedics Biomaterials Sales Volume by Region (2020-2025)
5.2.3 Global Orthopedics Biomaterials Sales Volume by Region (2026-2031)
5.2.4 Global Orthopedics Biomaterials Sales Volume by Region (%), (2020-2031)
5.3 Global Orthopedics Biomaterials Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Orthopedics Biomaterials Sales Value, 2020-2031
5.4.2 North America Orthopedics Biomaterials Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Orthopedics Biomaterials Sales Value, 2020-2031
5.5.2 Europe Orthopedics Biomaterials Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Orthopedics Biomaterials Sales Value, 2020-2031
5.6.2 Asia Pacific Orthopedics Biomaterials Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Orthopedics Biomaterials Sales Value, 2020-2031
5.7.2 South America Orthopedics Biomaterials Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Orthopedics Biomaterials Sales Value, 2020-2031
5.8.2 Middle East & Africa Orthopedics Biomaterials Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Orthopedics Biomaterials Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Orthopedics Biomaterials Sales Value and Sales Volume
6.2.1 Key Countries/Regions Orthopedics Biomaterials Sales Value, 2020-2031
6.2.2 Key Countries/Regions Orthopedics Biomaterials Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Orthopedics Biomaterials Sales Value, 2020-2031
6.3.2 United States Orthopedics Biomaterials Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Orthopedics Biomaterials Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Orthopedics Biomaterials Sales Value, 2020-2031
6.4.2 Europe Orthopedics Biomaterials Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Orthopedics Biomaterials Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Orthopedics Biomaterials Sales Value, 2020-2031
6.5.2 China Orthopedics Biomaterials Sales Value by Type (%), 2024 VS 2031
6.5.3 China Orthopedics Biomaterials Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Orthopedics Biomaterials Sales Value, 2020-2031
6.6.2 Japan Orthopedics Biomaterials Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Orthopedics Biomaterials Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Orthopedics Biomaterials Sales Value, 2020-2031
6.7.2 South Korea Orthopedics Biomaterials Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Orthopedics Biomaterials Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Orthopedics Biomaterials Sales Value, 2020-2031
6.8.2 Southeast Asia Orthopedics Biomaterials Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Orthopedics Biomaterials Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Orthopedics Biomaterials Sales Value, 2020-2031
6.9.2 India Orthopedics Biomaterials Sales Value by Type (%), 2024 VS 2031
6.9.3 India Orthopedics Biomaterials Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Arctic Biomaterials
7.1.1 Arctic Biomaterials Company Information
7.1.2 Arctic Biomaterials Introduction and Business Overview
7.1.3 Arctic Biomaterials Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Arctic Biomaterials Orthopedics Biomaterials Product Offerings
7.1.5 Arctic Biomaterials Recent Development
7.2 Zimmer Biomet
7.2.1 Zimmer Biomet Company Information
7.2.2 Zimmer Biomet Introduction and Business Overview
7.2.3 Zimmer Biomet Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Zimmer Biomet Orthopedics Biomaterials Product Offerings
7.2.5 Zimmer Biomet Recent Development
7.3 Evonik
7.3.1 Evonik Company Information
7.3.2 Evonik Introduction and Business Overview
7.3.3 Evonik Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Evonik Orthopedics Biomaterials Product Offerings
7.3.5 Evonik Recent Development
7.4 Geistlich Pharma AG
7.4.1 Geistlich Pharma AG Company Information
7.4.2 Geistlich Pharma AG Introduction and Business Overview
7.4.3 Geistlich Pharma AG Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Geistlich Pharma AG Orthopedics Biomaterials Product Offerings
7.4.5 Geistlich Pharma AG Recent Development
7.5 Invibio
7.5.1 Invibio Company Information
7.5.2 Invibio Introduction and Business Overview
7.5.3 Invibio Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Invibio Orthopedics Biomaterials Product Offerings
7.5.5 Invibio Recent Development
7.6 Medbone
7.6.1 Medbone Company Information
7.6.2 Medbone Introduction and Business Overview
7.6.3 Medbone Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Medbone Orthopedics Biomaterials Product Offerings
7.6.5 Medbone Recent Development
7.7 Medtronic
7.7.1 Medtronic Company Information
7.7.2 Medtronic Introduction and Business Overview
7.7.3 Medtronic Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Medtronic Orthopedics Biomaterials Product Offerings
7.7.5 Medtronic Recent Development
7.8 Olympus Corporation
7.8.1 Olympus Corporation Company Information
7.8.2 Olympus Corporation Introduction and Business Overview
7.8.3 Olympus Corporation Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Olympus Corporation Orthopedics Biomaterials Product Offerings
7.8.5 Olympus Corporation Recent Development
7.9 OSARTIS GmbH
7.9.1 OSARTIS GmbH Company Information
7.9.2 OSARTIS GmbH Introduction and Business Overview
7.9.3 OSARTIS GmbH Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 OSARTIS GmbH Orthopedics Biomaterials Product Offerings
7.9.5 OSARTIS GmbH Recent Development
7.10 SigmaGraft Biomaterials
7.10.1 SigmaGraft Biomaterials Company Information
7.10.2 SigmaGraft Biomaterials Introduction and Business Overview
7.10.3 SigmaGraft Biomaterials Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 SigmaGraft Biomaterials Orthopedics Biomaterials Product Offerings
7.10.5 SigmaGraft Biomaterials Recent Development
7.11 Stratasys
7.11.1 Stratasys Company Information
7.11.2 Stratasys Introduction and Business Overview
7.11.3 Stratasys Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Stratasys Orthopedics Biomaterials Product Offerings
7.11.5 Stratasys Recent Development
7.12 Stryker
7.12.1 Stryker Company Information
7.12.2 Stryker Introduction and Business Overview
7.12.3 Stryker Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Stryker Orthopedics Biomaterials Product Offerings
7.12.5 Stryker Recent Development
7.13 Terumo Corporation
7.13.1 Terumo Corporation Company Information
7.13.2 Terumo Corporation Introduction and Business Overview
7.13.3 Terumo Corporation Orthopedics Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Terumo Corporation Orthopedics Biomaterials Product Offerings
7.13.5 Terumo Corporation Recent Development
8 Industry Chain Analysis
8.1 Orthopedics Biomaterials Industrial Chain
8.2 Orthopedics Biomaterials Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Orthopedics Biomaterials Sales Model
8.5.2 Sales Channel
8.5.3 Orthopedics Biomaterials Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Orthopedics Biomaterials market is projected to grow from US$ 704 million in 2025 to US$ 1109 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 159
USD 4900.00
(Single User License)
The global Orthopedics Biomaterials market size was US$ 704 million in 2025 and is forecast to reach a readjusted size of US$ 1109 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 94
USD 4250.00
(Single User License)
The global market for Orthopedics Biomaterials was estimated to be worth US$ 704 million in 2025 and is projected to reach US$ 1109 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 115
USD 3950.00
(Single User License)
The global Orthopedics Biomaterials market was valued at US$ 704 million in 2025 and is anticipated to reach US$ 1109 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 143
USD 2900.00
(Single User License)
The global market for Orthopedics Biomaterials was valued at US$ 673 million in the year 2024 and is projected to reach a revised size of US$ 1045 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published Date: 2025-06-08
Pages: 98
USD 2900.00
(Single User License)
The global Orthopedics Biomaterials market size was US$ 673 million in 2024 and is forecast to a readjusted size of US$ 1045 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-06-08
Pages: 99
USD 4250.00
(Single User License)
The global Orthopedics Biomaterials market is projected to grow from US$ 704 million in 2025 to US$ 1045 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published Date: 2025-06-08
Pages: 160
USD 4900.00
(Single User License)
The global Orthopedics Biomaterials market is projected to grow from US$ 704 million in 2025 to US$ 1109 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 159
The global Orthopedics Biomaterials market size was US$ 704 million in 2025 and is forecast to reach a readjusted size of US$ 1109 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 94
The global market for Orthopedics Biomaterials was estimated to be worth US$ 704 million in 2025 and is projected to reach US$ 1109 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-03-09
Pages: 115
The global Orthopedics Biomaterials market was valued at US$ 704 million in 2025 and is anticipated to reach US$ 1109 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-03-09
Pages: 143
The global market for Orthopedics Biomaterials was valued at US$ 673 million in the year 2024 and is projected to reach a revised size of US$ 1045 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-06-08
Pages: 98
The global Orthopedics Biomaterials market size was US$ 673 million in 2024 and is forecast to a readjusted size of US$ 1045 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-06-08
Pages: 99
The global Orthopedics Biomaterials market is projected to grow from US$ 704 million in 2025 to US$ 1045 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published: 2025-06-08
Pages: 160
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now